How the pandemic elevated cancer telehealth and changed care delivery

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In early 2020, telehealth was a hot new trend in patient care, but with utilization sporadic and episodic at best, providers were generally skeptical as to whether this virtual technique of delivering care was a viable option for advanced clinical services, especially in oncology.  

Our attitude quickly changed as governments initiated COVID lockdowns across the country. Even though essential patient visits were allowed, including for cancer treatment, many patients became hesitant to travel outside the home—especially to a hospital. 

Since cancer doesn’t wait, we were suddenly forced to incorporate telehealth into cancer care wherever possible to mitigate the risk of COVID transmission to patients. This new way of delivering care was adopted, utilized and valued—among patients and providers—within a few short weeks.  

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
George Yoo, MD
Head and neck surgical oncologist, Chief medical officer and director of clinical affairs, Karmanos Cancer Institute in Detroit, a part of McLaren Health Care; Professor, Departments of Otolaryngology-Head and Neck Surgery and Oncology, Wayne State University School of Medicine
Table of Contents

YOU MAY BE INTERESTED IN

George Yoo, MD
Head and neck surgical oncologist, Chief medical officer and director of clinical affairs, Karmanos Cancer Institute in Detroit, a part of McLaren Health Care; Professor, Departments of Otolaryngology-Head and Neck Surgery and Oncology, Wayne State University School of Medicine

Login